Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Atlas Arteria ( (AU:ALX) ) has provided an update.
Atlas Arteria has filed an application for a toll price increase at the Dulles Greenway in Virginia, seeking approval from the State Corporation Commission. This request, which follows stakeholder sessions with various Virginia state entities, proposes increases for both peak and off-peak tolls, marking the first peak toll increase request since 2019. The decision’s timing is uncertain, but if approved, the new rates will be implemented immediately, potentially impacting the company’s revenue and stakeholder interests.
The most recent analyst rating on (AU:ALX) stock is a Buy with a A$5.70 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a company that partners to deliver world-class road experiences, focusing on creating long-term value through disciplined management and sustainable practices. The company operates toll road businesses in France, Germany, and the United States, including interests in the APRR, AREA, A79, and ADELAC motorway network in France, the Chicago Skyway in the US, and the Warnow Tunnel in Germany.
Average Trading Volume: 2,078,190
Technical Sentiment Signal: Hold
Current Market Cap: A$6.99B
For detailed information about ALX stock, go to TipRanks’ Stock Analysis page.